Global Creatinine Test Market: Information by Test Type (Blood Test, Urine Test and Creatinine Clearance Test), Product Type (Consumables and Instruments), Application (Urinary Tract Obstruction, Renal Failure, Kidney Cancer and Glomerulonephritis), End User (Hospital and Clinics, Diagnostic Centre and Research Institutes) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027
ID: MRFR/LS/3449-CR | July 2019 | Region: Global | 188 pages
Market Overview
The Global Creatinine Test Market is expected to register a CAGR of 5.80% and is anticipated to reach USD 604.55 Million by 2023. Creatinine testing is used to monitor progression and treatment of acute kidney injury and chronic kidney disease (CKD). It is basically of three types, namely, serum creatinine test, urine test, and creatinine clearance test. Serum creatinine is combined with measurements of urine creatinine to generate the creatinine clearance, an indicator of the glomerular filtration rate (GFR). Serum creatinine can also be used together with demographic information to calculate an estimated GFR (eGFR).
Prevalence of chronic kidney disease, technological advancements in the kidney function testing, initiatives taken by the government to control chronic kidney diseases are the major drivers propelling market growth. However, false estimates of creatinine testing may constrain the growth of the market.
Market Dynamics
Prevalence of chronic kidney disease, technological advancements in the kidney function testing, initiatives taken by the government to control chronic kidney diseases are the factors that boost the growth of the market. For instance, in February 2018, Siemens Healthineers received an FDA approval for its blood urea nitrogen (BUN) and total carbon dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances. Whereas false estimates of creatinine testing may constrain the growth of the market.
Global Creatinine Test Market Size, by Product Type, 2016 & 2023 (USD Million) 
Source: MRFR Analysis
Segmentation
The global creatinine test market has been segmented into test type, product type, application, the end user. Based on test type, the market has been segmented into a blood test, urine test, and creatinine test. Based on product type, the market has been divided into consumables and instruments. The consumables segment held a market share of 238.96 in 2016. Based on application, the market has been segregated into urinary tract obstruction, renal failure, kidney failure, and glomerulonephritis. Based on end user, the market has been bifurcated into hospital and clinics, diagnostic center, and research institutes.
Key Players
The prominent players in the global creatinine test market are Siemens, Abbott, Thermo Fisher Scientific Inc., Roche, and Danaher.
Some of the key strategies followed by the players operating in the global creatinine test market were acquisitions, collaborations and partnerships, product launches, and others.
Asia-Pacific Creatinine Test Market Share, by Country, 2016 (%) 
Source: MRFR Analysis
Regional Analysis
The global creatinine test market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global creatinine test market during the forecast period. This is attributed to the rising prevalence of various kidney diseases, well-developed technology, high healthcare expenditure, and the presence of leading players. Europe accounts for the second-largest creatinine market. The major driving factors of the market are increasing government support, rising healthcare expenditure, and well-developed technology.
Asia-Pacific is estimated to be the fastest-growing market due to the increasing demand for early diagnosis, rapidly improving technology, and the presence of a vast patient pool. The initiatives taken by the government to control chronic kidney diseases are also boosting the growth of the market. China held a market share of 22.6% in 2016. Furthermore, the market in the Middle East & Africa is expected to hold the least share in the market owing to the presence of poor and slow developing countries, especially in the African region.
Key Updates
- In February 2018, Siemens Healthineers received an FDA approval for its Blood Urea Nitrogen (BUN) and Total Carbon Dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances
- In November 2017, F Hoffmann-La Roche Ltd acquired Viewics, Inc. to expand its leading position in the Integrated Core Lab with business analytics capabilities.
- In August 2017, Nova Biomedical gained the CE mark certification for Stat Profile Prime Plus and is now available in all CE regulated countries.
Market Segmentation
Global Creatinine Test Market, by Test Type
- Blood Test
- Urine Test
- Creatinine Clearance Test
Global Creatinine Test Market, by Product Type
- Consumables
- Instruments
Global Creatinine Test Market, by Application
- Urinary Tract Obstruction
- Renal Failure
- Kidney Cancer
- Glomerulonephritis
Global Creatinine Test Market, by End User
- Hospital & Clinics
- Diagnostic Centre
- Research Institutes
Global Creatinine Test Market, by Region
- Americas
- North America
- US
- Canada
- South America
- North America
- Europe
- Western Europe
- Germany
- UK
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Republic of Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Available Additional Customizations
- Additional Companies
- BioAssay Systems
- Abcam PLC
- Arbor Assays
- Randox Laboratories Ltd
- DiaSys Diagnostic Systems GmbH
- MedTest Holdings, Inc. (Pointe Scientific, Inc.)
- Challenges in Global Creatinine Market
Intended Audience
- Medical device manufacturers and distributors
- Government research organizations
- Hospitals and clinics
- Regulatory agencies
- Pharmaceutical companies
Frequently Asked Questions (FAQ) :
Creatinine test market projected to grow at approximately 5.80% CAGR during the assessment period (2020-2027).
The valuation of the global creatinine test market is estimated to increase to USD 604.55 MN by the end of 2023.
Increasing demand for diagnosis of kidney disease and rising healthcare expenses are major tailwinds pushing the growth of the global creatinine test market.
North America holds the largest share in the global creatinine test market, followed by Europe and the Asia Pacific, respectively.
Merck (U.S.), Quest Diagnostics (U.S.), Sonic Healthcare (Australia), Beckman Coulter (U.S.), Bayer (U.S.), Laboratory Corporation of America Holdings (U.S.), Healthscope (Australia), Genoptix (U.S.), Labco (Kuwait), OPKO Health, Inc. (U.S.), Charles River (U.S.), and Abbott (U.S.), are some of the top players operating in the global creatinine test market.
Global Creatinine Test Market: Report Summary
The global creatinine test market is anticipated to reach a valuation of USD 604.55 million by 2023, expanding at a 5.8% CAGR during the assessment period (2018-2023). Alarming cases of kidney disorders, namely chronic kidney disease (CKD) among patients is expected to be the primary driver of the market. In addition, government initiatives by various nations to create awareness among patients can propel market demand in the coming years.
Creatinine tests are an array of tests used to discern creatinine levels in the blood. Creatinine is a waste product created during the breakdown of creatine, an organic acid found in vertebrates. Development of various tests such as blood urea nitrogen (BUN) test, estimated glomerular filtration rate (eGFR) test, and others can provide accurate results and assist in preventive healthcare. The rise in the geriatric populace and increasing cases of diabetics can purportedly drive the demand for creatinine tests over the forecast period.
The creatinine test market has been segmented by test type, product type, application, end-user, and region. By type, the market is segmented into blood test, creatinine clearance test, and urine test. The blood test segment is expected to generate market revenue owing to high preference of blood tests to measure creatinine levels. It was worth USD 211.83 million in 2016 and purportedly expand at a 5.32% CAGR during the forecast period. The urine test segment can grow robustly over the forecast period owing to advances in urine test strips to determine a rapid and accurate diagnosis of kidney disorders.
By product type, the market is segmented into consumables and instruments. The consumables segment is likely to register a remarkable growth rate during the forecast period owing to urine test strips and cartridges being used for rapid diagnosis of creatinine in the urine. The instruments segment is projected to grow at a brisk pace and exhibit a 6% CAGR during the forecast period.
On the basis of application, the market has been segmented into kidney cancer, renal failure, glomerulonephritis, urinary tract obstruction, and others. The urinary tract obstruction segment is expected to showcase a 5.10% CAGR over the forecast period owing to serum creatinine tests used to determine blockage of the urinary tract.
Major market end-users include research institutes, diagnostic centers, hospitals and clinics, and others. The diagnostic centers segment is projected to register a 6.34% CAGR during the forecast period owing to high demand for early diagnosis of CKD.
Regional Analysis
On the basis of regions, the global creatinine test market has been segmented into Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).
The Americas market accounted for a large market share owing to presence of various leaders of the healthcare industry, expanded healthcare budget, reimbursement policies, and prevalence of various kidney diseases. According to a 2017 report by the National Center for Chronic Disease and Prevention, nearly 30 million citizens in the U.S. were dealing with some form of kidney disorder. Inclination towards quality healthcare is expected to bode well for the market over the forecast period.
The Europe market is expected to exhibit a 6.12% CAGR from 2017 to 2023. Countries such as the U.K., France, and Germany are projected to contribute to market demand owing to change in healthcare policies.
The APAC market is deemed to grow at a rapid pace during the forecast period owing to a large patient pool, improving healthcare infrastructure, and changing healthcare models of hospitals. It is expected to exhibit a 6.33% CAGR from 2017 to 2023 owing to helpful government initiatives to create awareness and subsidies offered to hospitals for implementation of rapid diagnostic tests.
Competitive Analysis
Siemens AG, Abcam plc, ACON Laboratories, Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Quest Diagnostics, URIT Medical, The Danaher Corporation, Abbott Diagnostics Inc., Nova Biomedical, OPTI Medical Systems, ARKRAY, Inc., and others are some of the noteworthy players in the creatinine test market. Acquisitions and new product launches are strategies employed by players to gain a larger share in the market. Development of new standards by regulatory agencies to ease the approval process of new product launches is expected to open up new growth opportunities for the market. For instance, BUN and total carbon dioxide (TCO2) point-of-care tests by Siemens Healthcare were approved in 2018 by the U.S. Food and Drug Administration (FDA) to assist in the diagnosis of renal diseases.
1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition 23
3.2 Scope Of The Study 23
3.3 Assumptions & Limitations 23
3.3.1 Assumptions 23
3.3.2 Limitations 23
3.4 Market Structure 24
4 Research Methodology
4.1 Research Process 26
4.2 Primary Research 27
4.3 Secondary Research 28
4.4 Market Size Estimation 29
4.5 Forecast Model 29
5 Market Dynamics
5.1 Introduction 31
5.2 Drivers 32
5.2.1 Prevalence Of Chronic Kidney Disease 32
5.2.2 Technological Advancements In The Kidney Function Testing 32
5.2.3 Initiatives Taken By Government To Control Chronic Kidney Diseases 33
5.3 Restraints 33
5.3.1 False Estimates Of Creatinine Testing 33
5.4 Opportunities 33
5.4.1 Rising Approval From FDA 33
5.5 Macroeconomic Indicators 34
6 Market Factor Analysis
6.1 Supply Chain Analysis 36
6.1.1 R&D 36
6.1.2 Parts Manufacturing 36
6.1.3 Distribution 36
6.1.4 Marketing & Sales 36
6.1.5 Post–Sales Monitoring 36
6.2 Demand & Supply: Gap Analysis 37
6.3 Pricing Analysis 37
6.4 Investment Opportunities 37
6.5 Porter’s Five Forces Model 38
6.5.1 Bargaining Power Of Suppliers 38
6.5.2 Bargaining Power Of Buyers 38
6.5.3 Threat Of New Entrants 39
6.5.4 Threat Of Substitutes 39
6.5.5 Intensity Of Rivalry 39
7 Creatinine Test Market, By Test Type
7.1 Overview 41
7.1.1 Blood Test 41
7.1.2 Urine Test 41
7.1.3 Creatinine Clearance Test 41
8 Creatinine Test Market, By Product Type
8.1 Overview 46
8.1.1 Consumables 46
8.1.2 Instruments 46
9 Creatinine Test Market, By Application
9.1 Overview 51
9.1.1 Urinary Tract Obstruction 51
9.1.2 Renal Failure 51
9.1.3 Kidney Cancer 51
9.1.4 Glomerulonephritis 51
10 Creatinine Test Market, By End User
10.1 Overview 55
10.1.1 Hospital & Clinics 55
10.1.2 Diagnostic Centre 55
10.1.3 Research Institutes 55
11 Creatinine Test Market, By Region
11.1 Introduction 59
11.2 Americas 61
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.2.1 North America 65
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.2.1.1 US. 68
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.2.1.2 Canada 71
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.2.2 South America 74
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.3 Europe 78
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.3.1 Western Europe 82
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.3.1.1 Germany 85
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.3.1.2 UK 91
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.3.1.3 Italy 94
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.3.1.4 Spain 97
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.3.1.5 Rest Of Western Europe 100
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.3.2 Eastern Europe 103
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.4 Asia–Pacific 107
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.4.1 Japan 111
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.4.2 China 114
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.4.3 India 117
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.4.4 Australia 120
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.4.5 South Korea 123
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.4.6 Rest Of Asia–Pacific 126
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.5 The Middle East And Africa 130
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.5.1 Middle East 134
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
11.5.2 Africa 137
Creatinine Test Market, By Test Type
Creatinine Test Market, By Product Type
Creatinine Test Market, By Application
Creatinine Test Market, By End User
12 Competitive Landscape
12.1 Company Market Share Analysis 141
12.1.1 Introduction 141
12.2 Competitive Landscape 142
12.2.1 Introduction 142
12.3 Key Developments 143
13 Company Profiles
13.1 Siemens AG 145
13.1.1 Company Overview 145
13.1.2 Financial Overview 145
13.1.3 Products Offerings 146
13.1.4 Key Developments 146
13.1.5 SWOT Analysis 146
13.1.6 Key Strategy 147
13.2 Abbott 148
13.2.1 Company Overview 148
13.2.2 Financial Overview 148
13.2.3 Products Offerings 148
13.2.4 Key Developments 149
13.2.5 SWOT Analysis 149
13.2.6 Key Strategy 149
13.3 Thermo Fisher Scientific Inc 150
13.3.1 Company Overview 150
13.3.2 Financial Overview 150
13.3.3 Products Offerings 151
13.3.4 Key Developments 151
13.3.5 SWOT Analysis 151
13.3.6 Key Strategy 151
13.4 Abcam PLC 152
13.4.1 Company Overview 152
13.4.2 Financial Overview 152
13.4.3 Products Offerings 152
13.4.4 Key Developments 153
13.4.5 SWOT Analysis 153
13.4.6 Key Strategy 153
13.5 F. Hoffmann–La Roche AG 154
13.5.1 Company Overview 154
13.5.2 Financial Overview 154
13.5.3 Products Offerings 155
13.5.4 Key Developments 155
13.5.5 SWOT Analysis 155
13.5.6 Key Strategy 155
13.6 Nova Biomedical 156
13.6.1 Company Overview 156
13.6.2 Products Offerings 156
13.6.3 Key Developments 156
13.6.4 SWOT Analysis 157
13.6.5 Key Strategy 157
13.7 ACON Laboratories, Inc. 158
13.7.1 Company Overview 158
13.7.2 Products Offerings 158
13.7.3 Key Developments 158
13.7.4 SWOT Analysis 158
13.7.5 Key Strategy 158
13.8 OPTI Medical Systems 159
13.8.1 Company Overview 159
13.8.2 Products Offerings 159
13.8.3 Key Developments 159
13.8.4 SWOT Analysis 159
13.8.5 Key Strategy 159
13.9 URIT Medical 160
13.9.1 Company Overview 160
13.9.2 Products Offerings 160
13.9.3 Key Developments 160
13.9.4 SWOT Analysis 160
13.9.5 Key Strategy 160
13.10 Quest Diagnostics 161
13.10.1 Company Overview 161
13.10.2 Financial Overview 161
13.10.3 Products Offerings 162
13.10.4 Key Developments 162
13.10.5 SWOT Analysis 162
13.10.6 Key Strategy 162
13.11 ARKRAY, Inc. 163
13.11.1 Company Overview 163
13.11.2 Products Offerings 163
13.11.3 Key Developments 163
13.11.4 SWOT Analysis 163
13.11.5 Key Strategy 163
13.12 Danaher 164
13.12.1 Company Overview 164
13.12.2 Products Offerings 165
13.12.3 Key Developments 165
13.12.4 SWOT Analysis 165
13.12.5 Key Strategy 165
14 Conclusion
14.1 Key Findings 167
14.1.1 CEO’s Viewpoint 167
14.1.2 Unmet Needs 167
14.1.3 Key Companies To Watch 167
14.1.4 Prediction 167
15 Appendix
15.1 Discussion Blue Print 169
15.2 References 170
16 List Of Tables
TABLE 1 MARKET SYNOPSIS 21
TABLE 2 PRIMARY INTERVIEWS 27
TABLE 3 GLOBAL CREATININE TEST MARKET FOR BLOOD TEST, BY REGION 2020–2027 (USD MILLION) 42
TABLE 4 GLOBAL CREATININE TEST MARKET FOR SERUM CREATININE TEST, BY REGION 2020–2027 (USD MILLION) 42
TABLE 5 GLOBAL CREATININE TEST MARKET FOR EGFR TEST, BY REGION 2020–2027 (USD MILLION) 43
TABLE 6 GLOBAL CREATININE TEST MARKET FOR BLOOD UREA NITROGEN TEST, BY REGION 2020–2027 (USD MILLION) 43
TABLE 7 GLOBAL CREATININE TEST MARKET FOR URINE TEST, BY REGION 2020–2027 (USD MILLION) 43
TABLE 8 GLOBAL CREATININE TEST MARKET FOR A: C TEST, BY REGION 2020–2027 (USD MILLION) 44
TABLE 9 GLOBAL CREATININE TEST MARKET FOR P: C TEST, BY REGION 2020–2027 (USD MILLION) 44
TABLE 10 GLOBAL CREATININE TEST MARKET FOR CREATININE CLEARANCE TEST, BY REGION 2020–2027 (USD MILLION) 44
TABLE 11 GLOBAL CREATININE TEST MARKET FOR CONSUMABLE, BY REGION 2020–2027 (USD MILLION) 47
TABLE 12 GLOBAL CREATININE TEST MARKET FOR URINE TEST STRIPS, BY REGION 2020–2027 (USD MILLION) 47
TABLE 13 GLOBAL CREATININE TEST MARKET FOR CARTRIDGE, BY REGION 2020–2027 (USD MILLION) 47
TABLE 14 GLOBAL CREATININE TEST MARKET FOR INSTRUMENTS, BY REGION 2020–2027 (USD MILLION) 48
TABLE 15 GLOBAL CREATININE TEST MARKET FOR CLINICAL ANALYZER, BY REGION 2020–2027 (USD MILLION) 48
TABLE 16 GLOBAL CREATININE TEST MARKET FOR BENCH TOP CLINICAL ANALYZER, BY REGION 2020–2027 (USD MILLION) 48
TABLE 17 GLOBAL CREATININE TEST MARKET FOR AUTOMATED, BY REGION 2020–2027 (USD MILLION) 49
TABLE 18 GLOBAL CREATININE TEST MARKET FOR SEMI AUTOMATED, BY REGION 2020–2027 (USD MILLION) 49
TABLE 19 GLOBAL CREATININE TEST MARKET FOR HANDHELD CLINICAL ANALYZER, BY REGION 2020–2027 (USD MILLION) 49
TABLE 20 GLOBAL CREATININE TEST MARKET FOR URINARY TRACT OBSTRUCTION, BY REGION 2020–2027 (USD MILLION) 52
TABLE 21 GLOBAL CREATININE TEST MARKET FOR RENAL FAILURE, BY REGION 2020–2027 (USD MILLION) 52
TABLE 22 GLOBAL CREATININE TEST MARKET FOR KIDNEY CANCER, BY REGION 2020–2027 (USD MILLION) 53
TABLE 23 GLOBAL CREATININE TEST MARKET FOR GLOMERULONEPHRITIS, BY REGION 2020–2027 (USD MILLION) 53
TABLE 24 GLOBAL CREATININE TEST MARKET FOR HOSPITAL & CLINICS, BY REGION 2020–2027 (USD MILLION) 56
TABLE 25 GLOBAL CREATININE TEST MARKET FOR DIAGNOSTIC CENTER, BY REGION 2020–2027 (USD MILLION) 56
TABLE 26 GLOBAL CREATININE TEST MARKET FOR RESEARCH INSTITUTES, BY REGION 2020–2027 (USD MILLION) 57
TABLE 27 GLOBAL CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 59
TABLE 28 AMERICAS: CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 61
TABLE 29 AMERICAS: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 62
TABLE 30 AMERICAS CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 62
TABLE 31 AMERICAS CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 62
TABLE 32 AMERICAS: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 62
TABLE 33 AMERICAS: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 63
TABLE 34 AMERICAS: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 63
TABLE 35 AMERICAS: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 63
TABLE 36 AMERICAS: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 63
TABLE 37 AMERICAS: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 64
TABLE 38 AMERICAS: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 64
TABLE 39 NORTH AMERICA: CREATININE TEST MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 65
TABLE 40 NORTH AMERICA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 65
TABLE 41 NORTH AMERICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 65
TABLE 42 NORTH AMERICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 66
TABLE 43 NORTH AMERICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 66
TABLE 44 NORTH AMERICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 66
TABLE 45 NORTH AMERICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 66
TABLE 46 NORTH AMERICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 67
TABLE 47 NORTH AMERICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 67
TABLE 48 NORTH AMERICA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 67
TABLE 49 NORTH AMERICA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 68
TABLE 50 US: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 68
TABLE 51 US: CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 68
TABLE 52 US: CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 53 US: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 69
TABLE 54 US: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 55 US: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 56 US: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 70
TABLE 57 US: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 70
TABLE 58 US: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 70
TABLE 59 US: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 71
TABLE 60 CANADA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 71
TABLE 61 CANADA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 62 CANADA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 63 CANADA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 72
TABLE 64 CANADA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 65 CANADA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 66 CANADA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 73
TABLE 67 CANADA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 73
TABLE 68 CANADA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 73
TABLE 69 CANADA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 74
TABLE 70 SOUTH AMERICA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 74
TABLE 71 SOUTH AMERICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 72 SOUTH AMERICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 75
TABLE 73 SOUTH AMERICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 75
TABLE 74 SOUTH AMERICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 75
TABLE 75 SOUTH AMERICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 75
TABLE 76 SOUTH AMERICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 77 SOUTH AMERICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 78 SOUTH AMERICA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 76
TABLE 79 SOUTH AMERICA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 77
TABLE 80 EUROPE: CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 78
TABLE 81 EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 78
TABLE 82 EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 83 EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 84 EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 79
TABLE 85 EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 86 EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 87 EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 88 EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 89 EUROPE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 81
TABLE 90 EUROPE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 81
TABLE 91 WESTERN EUROPE: CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 82
TABLE 92 WESTERN EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 82
TABLE 93 WESTERN EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 82
TABLE 94 WESTERN EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 95 WESTERN EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 83
TABLE 96 WESTERN EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 97 WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 98 WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 99 WESTERN EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 100 WESTERN EUROPE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 84
TABLE 101 WESTERN EUROPE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 85
TABLE 102 GERMANY: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 85
TABLE 103 GERMANY CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 85
TABLE 104 GERMANY CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 86
TABLE 105 GERMANY: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 86
TABLE 106 GERMANY: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 86
TABLE 107 GERMANY: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 86
TABLE 108 GERMANY: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 87
TABLE 109 GERMANY: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 87
TABLE 110 GERMANY: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 87
TABLE 111 GERMANY: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 88
TABLE 112 FRANCE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 88
TABLE 113 FRANCE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 114 FRANCE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 115 FRANCE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 89
TABLE 116 FRANCE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 117 FRANCE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 118 FRANCE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 90
TABLE 119 FRANCE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 90
TABLE 120 FRANCE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 90
TABLE 121 FRANCE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 91
TABLE 122 UK: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 91
TABLE 123 UK: CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 124 UK: CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 92
TABLE 125 UK: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 92
TABLE 126 UK: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 92
TABLE 127 UK: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 92
TABLE 128 UK: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 129 UK: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 130 UK: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 93
TABLE 131 UK: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 94
TABLE 132 ITALY: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 94
TABLE 133 ITALY: CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 94
TABLE 134 ITALY: CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 135 ITALY: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 95
TABLE 136 ITALY: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 137 ITALY: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 138 ITALY: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 139 ITALY: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 140 ITALY: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 96
TABLE 141 ITALY: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 97
TABLE 142 SPAIN: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 97
TABLE 143 SPAIN CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 144 SPAIN CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 145 SPAIN: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 98
TABLE 146 SPAIN: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 147 SPAIN: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 148 SPAIN: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 149 SPAIN: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 150 SPAIN: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 99
TABLE 151 SPAIN: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 100
TABLE 152 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 100
TABLE 153 REST OF WESTERN EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 154 REST OF WESTERN EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 155 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 101
TABLE 156 REST OF WESTERN EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 157 REST OF WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 158 REST OF WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 159 REST OF WESTERN EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 160 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 102
TABLE 161 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 103
TABLE 162 EASTERN EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 103
TABLE 163 EASTERN EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 164 EASTERN EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 165 EASTERN EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 104
TABLE 166 EASTERN EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 167 EASTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 168 EASTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 169 EASTERN EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 170 EASTERN EUROPE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 105
TABLE 171 EASTERN EUROPE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 106
TABLE 172 ASIA-PACIFIC: CREATININE TEST MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 173 ASIA-PACIFIC: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 108
TABLE 174 ASIA-PACIFIC CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 175 ASIA-PACIFIC CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 176 ASIA-PACIFIC: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 109
TABLE 177 ASIA-PACIFIC: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 178 ASIA-PACIFIC: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 179 ASIA-PACIFIC: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 180 ASIA-PACIFIC: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 181 ASIA-PACIFIC: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 110
TABLE 182 ASIA-PACIFIC: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 111
TABLE 183 JAPAN: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 111
TABLE 184 JAPAN CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 185 JAPAN CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 186 JAPAN: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 112
TABLE 187 JAPAN: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 188 JAPAN: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 189 JAPAN: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 190 JAPAN: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 191 JAPAN: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 192 JAPAN: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 114
TABLE 193 CHINA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 114
TABLE 194 CHINA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 195 CHINA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 196 CHINA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 115
TABLE 197 CHINA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 198 CHINA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 199 CHINA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 200 CHINA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 201 CHINA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 116
TABLE 202 CHINA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 117
TABLE 203 INDIA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 117
TABLE 204 INDIA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 205 INDIA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 206 INDIA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 118
TABLE 207 INDIA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 208 INDIA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 209 INDIA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 210 INDIA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 211 INDIA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 119
TABLE 212 INDIA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 120
TABLE 213 AUSTRALIA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 120
TABLE 214 AUSTRALIA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 215 AUSTRALIA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 216 AUSTRALIA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 121
TABLE 217 AUSTRALIA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 218 AUSTRALIA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 219 AUSTRALIA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 220 AUSTRALIA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 221 AUSTRALIA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 122
TABLE 222 AUSTRALIA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 123
TABLE 223 SOUTH KOREA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 123
TABLE 224 SOUTH KOREA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 225 SOUTH KOREA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 226 SOUTH KOREA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 124
TABLE 227 SOUTH KOREA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 228 SOUTH KOREA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 229 SOUTH KOREA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 230 SOUTH KOREA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 231 SOUTH KOREA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 125
TABLE 232 SOUTH KOREA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 126
TABLE 233 REST OF ASIA-PACIFIC: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 126
TABLE 234 REST OF ASIA-PACIFIC CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 235 REST OF ASIA-PACIFIC CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 236 REST OF ASIA-PACIFIC: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 127
TABLE 237 REST OF ASIA-PACIFIC: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 238 REST OF ASIA-PACIFIC: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 239 REST OF ASIA-PACIFIC: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 240 REST OF ASIA-PACIFIC: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 241 REST OF ASIA-PACIFIC: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 242 REST OF ASIA-PACIFIC: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 129
TABLE 243 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 130
TABLE 244 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 131
TABLE 245 THE MIDDLE EAST AND AFRICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 246 THE MIDDLE EAST AND AFRICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 247 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 131
TABLE 248 THE MIDDLE EAST AND AFRICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 249 THE MIDDLE EAST AND AFRICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 250 THE MIDDLE EAST AND AFRICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 251 THE MIDDLE EAST AND AFRICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 252 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 133
TABLE 253 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 133
TABLE 254 MIDDLE EAST: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 134
TABLE 255 MIDDLE EAST CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 256 MIDDLE EAST CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 257 MIDDLE EAST: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 135
TABLE 258 MIDDLE EAST: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 259 MIDDLE EAST: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 260 MIDDLE EAST: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 261 MIDDLE EAST: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 262 MIDDLE EAST: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 136
TABLE 263 MIDDLE EAST: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 136
TABLE 264 AFRICA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 137
TABLE 265 AFRICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 266 AFRICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 267 AFRICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 138
TABLE 268 AFRICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 269 AFRICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 270 AFRICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 271 AFRICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 272 AFRICA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 273 AFRICA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 139
TABLE 274 GLOBAL CREATININE TEST MARKET: KEY DEVELOPMENT 143
17 List Of Figures
FIGURE 1 GLOBAL CREATININE TEST MARKET: MARKET STRUCTURE 24
FIGURE 2 RESEARCH PROCESS OF MRFR 26
FIGURE 3 TOP DOWN & BOTTOM UP APPROACH 29
FIGURE 4 MARKET DYNAMICS ANALYSIS OF GLOBAL CREATININE TEST MARKET 31
FIGURE 5 SUPPLY CHAIN: CREATININE TEST MARKET 36
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL CREATININE TEST MARKET 38
FIGURE 7 GLOBAL CREATININE TEST MARKET, BY TEST TYPE, 2020 (%) 41
FIGURE 8 GLOBAL CREATININE TEST MARKET, BY TEST TYPE, 2020 & 2027 (USD MILLION) 42
FIGURE 9 GLOBAL CREATININE TEST MARKET, BY PRODUCT TYPE, 2020 (%) 46
FIGURE 10 GLOBAL CREATININE TEST MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION) 46
FIGURE 11 GLOBAL CREATININE TEST MARKET, BY APPLICATION, 2020 (%) 51
FIGURE 12 GLOBAL CREATININE TEST MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 52
FIGURE 13 GLOBAL CREATININE TEST MARKET, BY END USER, 2020 (%) 55
FIGURE 14 GLOBAL CREATININE TEST MARKET, BY END USER, 2020 & 2027 (USD MILLION) 56
FIGURE 15 GLOBAL CREATININE TEST MARKET, BY REGION, 2020 & 2027 (USD MILLION) 59
FIGURE 16 GLOBAL CREATININE TEST MARKET, BY REGION, 2020 (%) 60
FIGURE 17 AMERICAS: CREATININE TEST MARKET SHARE, BY REGION, 2020 (%) 61
FIGURE 18 EUROPE: CREATININE TEST MARKET SHARE, BY REGION, 2020 (%) 78
FIGURE 19 ASIA-PACIFIC: CREATININE TEST MARKET SHARE, BY COUNTRY, 2020 (%) 107
FIGURE 20 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET SHARE, BY REGION, 2020 (%) 130
FIGURE 21 GLOBAL CREATININE TEST MARKET, MARKET SHARE ANALYSIS 2020 (%) 141
FIGURE 22 GLOBAL CREATININE TEST MARKET: COMPETITIVE LANDSCAPE 2020 (%) 142
Global Creatinine Test Market: Competitive Landscape
Siemens AG, Abbott Diagnostics Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche AG, and The Danaher Corporation collectively accounted for more than 70.5% market share of the global creatinine test market in 2016. These companies continue to retain their strong global presence through acquisitions and product launches.
In 2016, Siemens accounted for the largest market share of the global creatinine test market, with more than 21.2% of the market share. The large share of the company is attributed to the high demand for creatinine testing globally. Moreover, this company offers various new products in the creatinine test market. For instance, in 2018, Siemens Healthineers received an FDA approval for its Blood Urea Nitrogen (BUN) and Total Carbon Dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.
Abbott held the second position in terms of market share, in 2016. The company focuses on delivering integrated solutions to large healthcare customers. Also, the company is focusing on acquisitions for establishing a strong position in the market. For instance, in Oct 2017, Abbott completed the acquisition of Alere Inc. for USD 5.3 Billion. The acquisition will establish a strong position of Abbott in the diagnostics market.
Thermo Fisher Scientific Inc. acquired the third spot in the market. The company follows a strategy of introducing a strong product portfolio at lower costs which help them to retain the position in the market.
- Hoffmann-La Roche AG holds the fourth place in the market owing to the strategy of identifying & developing promising technologies and potential products and focusing on merging and acquisitions with other groups to develop and identify new products and technologies. For instance, in Nov 2017, Roche announced to acquire Viewics, Inc. to expand its leading position in the Integrated Core Lab with business analytics capabilities.
The Danaher Corporation is a global technology and science innovator focusing on helping their customers solve complex challenges and improve quality of life around the world. It holds the fifth position in the global creatinine test market owing to new launches and global presence in the market. In 2017, the company announced the launch of its CE-marked point-of-care tests for creatinine and urea, the latest additions to the ABL90 FLEX PLUS blood gas analyzer’s test menu.
There are many other players present in the market such as ARKRAY, Inc., Quest Diagnostics Inc., URIT Medical, OPTI Medical Systems, Inc., ACON Laboratories, Inc., Nova Biomedical, Abcam plc, and others which accounts cumulatively for nearly 29.5% of the global market share. The companies are adopting the strategy of product launches and acquisitions to solidify their position in the market. New product developments are a key focus area for players.
